Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Condition:   Liver, Cancer of, Primary Resectable Interventions:   Drug: Oxaliplatin;   Drug: Doxorubicin;   Drug: Lobaplatin;   Drug: Cisplatin;   Drug: Oxaliplatin, Leucovorin, fluorouracil;   Drug: Lobaplatin, Raltitrexed Sponsor:   Zhujiang Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials